ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ: ORIC
· Real-Time Price · USD
9.72
-0.21 (-2.11%)
At close: Aug 15, 2025, 3:59 PM
9.62
-1.03%
After-hours: Aug 15, 2025, 07:13 PM EDT
ORIC Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.07M | 1.07M | 1.07M | 1.54M | 1.54M | 1.54M | 1.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.42M | 1.38M | 1.34M | 1.07M | 1.05M | 1.04M | 1.03M | 1.02M | 980K | 968K | 966K | 948K | 944K | 919K | 897K | 668K | 451K | 229K |
Gross Profit | -349K | -311K | -270K | 472K | 485K | 498K | 506K | -1.02M | -980K | -968K | -966K | -948K | -944K | -919K | -897K | -668K | -451K | -229K |
Operating Income | -149.67M | -146.62M | -142.9M | -134.75M | -125.12M | -114.09M | -110.78M | -101.47M | -98.48M | -94.19M | -91.77M | -92.45M | -85.22M | -85.58M | -78.87M | -84.35M | -91.49M | -81.56M |
Interest Income | n/a | 4.05M | 8.03M | 11.13M | 14.34M | 12.33M | 10.08M | 8.26M | 5.92M | 4.28M | 2.65M | 1.41M | 572K | 196K | 141K | 137K | 117K | 109K |
Pretax Income | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M | -100.7M | -93.21M | -92.56M | -89.91M | -89.12M | -91.05M | -84.64M | -85.36M | -78.72M | -84.2M | -91.33M | -81.34M |
Net Income | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M | -98.71M | -89.96M | -88.44M | -85.78M | -86.89M | -90.08M | -84.54M | -85.27M | -78.72M | -84.2M | -91.33M | -81.34M |
Selling & General & Admin | 31.31M | 29.87M | 28.56M | 27.65M | 26.82M | 25.95M | 25.34M | 24.48M | 24.16M | 24.82M | 25.09M | 25.32M | 24.91M | 23.59M | 22.01M | 20.25M | 18.49M | 16.35M |
Research & Development | 118.36M | 116.75M | 114.07M | 106.58M | 97.77M | 87.62M | 85.17M | 76.99M | 69.32M | 64.37M | 61.68M | 62.13M | 60.31M | 61.99M | 56.86M | 52.23M | 48.16M | 40.36M |
Other Expenses | n/a | n/a | n/a | 263K | 263K | 2.31M | 2.31M | 7.05M | 12.05M | 10.41M | 10.41M | 5.41M | 409K | 15K | 15K | 8K | 52K | 111K |
Operating Expenses | 149.67M | 146.62M | 142.63M | 134.49M | 124.86M | 113.83M | 110.78M | 101.47M | 93.48M | 89.19M | 86.77M | 87.45M | 85.22M | 85.58M | 78.87M | 72.48M | 66.65M | 56.72M |
Interest Expense | n/a | n/a | n/a | 1.99M | 1.99M | 1.99M | 1.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -261K | -524K | -524K | -524K | -263K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 149.67M | 146.62M | 142.9M | 134.75M | 125.12M | 114.09M | 110.78M | 101.47M | 93.48M | 89.19M | 86.77M | 87.45M | 85.22M | 85.58M | 78.87M | 72.48M | 66.65M | 56.72M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 136.91K | -1.85M | -3.12M | -3.99M | -4.12M | -2.24M | -998K | -163K | -196K | -185K | -181K | -161K | -153K |
Shares Outstanding (Basic) | 78.13M | 71.04M | 70.65M | 70.54M | 70.35M | 67.35M | 57.46M | 57.4M | 45.65M | 45.09M | 40.18M | 39.58M | 39.48M | 39.43M | 39.39M | 39.01M | 36.7M | 36.68M |
Shares Outstanding (Diluted) | 78.13M | 71.04M | 70.65M | 70.54M | 70.35M | 67.35M | 57.46M | 57.4M | 45.65M | 45.09M | 40.18M | 39.58M | 39.48M | 39.43M | 39.39M | 39.01M | 36.7M | 36.68M |
EPS (Basic) | -1.89 | -1.87 | -1.82 | -1.8 | -1.75 | -1.8 | -1.92 | -1.92 | -2.09 | -2.1 | -2.19 | -2.28 | -2.14 | -2.2 | -2.07 | -2.33 | -2.7 | -2.64 |
EPS (Diluted) | -1.89 | -1.87 | -1.82 | -1.8 | -1.75 | -1.8 | -1.92 | -1.92 | -2.09 | -2.1 | -2.19 | -2.28 | -2.14 | -2.2 | -2.07 | -2.33 | -2.7 | -2.64 |
EBITDA | -149.1M | -145.78M | -141.79M | -133.69M | -124.06M | -113.05M | -109.75M | -100.45M | -92.5M | -88.22M | -85.8M | -86.5M | -84.27M | -84.66M | -77.97M | -71.57M | -65.73M | -55.77M |
EBIT | -141M | -140.66M | -139.63M | -134.75M | -125.12M | -114.09M | -110.78M | -101.47M | -93.48M | -89.19M | -86.77M | -87.45M | -85.22M | -85.58M | -78.87M | -72.48M | -66.65M | -56.72M |
Depreciation & Amortization | 876K | 1.15M | 1.11M | 1.07M | 1.05M | 1.04M | 1.03M | 1.02M | 980K | 968K | 966K | 948K | 944K | 919K | 897K | 902K | 925K | 949K |